Cornea News and Research

RSS

International Stem Cell announces strategic alliance with TAP

International Stem Cell Corporation, www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership, www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue.

18 May 2010

Phakic IOLs safer than laser surgery for correcting moderate short-sightedness

A new type of procedure for correcting short-sightedness could be safer than laser eye surgery, according to a new Cochrane Systematic Review. The study also shows that patients prefer the new procedure, despite there being little difference between the two in terms of improving vision.

12 May 2010

NEI renews K12 grant for Mass. Eye and Ear to fund Harvard Vision Clinical Scientist Development Program

The Massachusetts Eye and Ear Infirmary, Harvard Medical School Department of Ophthalmology, has been awarded a grant renewal from the National Institutes of Health, National Eye Institute (NEI), to recruit, train and support first-rate clinician scientists to promote translational and clinical research into cures for eye disease.

11 May 2010

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced the presentation of data on its novel resolvins for the treatment of both ocular surface diseases and retinal diseases at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida, being held May 2-6, 2010.

7 May 2010

Research may promote better diagnosis and treatment for glaucoma

Glaucoma, the second leading cause of blindness worldwide, tends to progress silently until decreased vision indicates trouble, said Dr. Kathryn Bollinger, Medical College of Georgia clinician-scientist specializing in glaucoma.

6 May 2010

New combination eye drops effective in treating bacterial keratitis

Scientists are reporting development of a potential new way of enabling patients with bacterial keratitis to stick with the extraordinarily intensive treatment needed for this potentially blinding eye infection.

6 May 2010

New light-activated Photochemical Tissue Bonding technology helps treat battlefield injuries

Airmen's traumatic battlefield injuries may be more effectively treated by using a new light-activated technology developed as a result of research managed by Air Force Office of Scientific Research and supported by funds from the Office of the Secretary of Defense.

4 May 2010

New tool may help neurologists predict candidates for organ donation

A new tool may help neurologists predict which coma patients may be candidates for organ donation, according to a study published in the April 27, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

3 May 2010

$Innovative new contact lens to correct hyperopia without refractive surgery$

Innovative new contact lens to correct hyperopia without refractive surgery

Jaume Pauné, a graduate of the Master's Degree in Optometry and Vision Sciences at the UPC-Barcelona Tech's College of Optics and Optometry, has designed an innovative new contact lens that will improve the vision quality of thousands of people without surgery. The Spanish Association of Opticians and Optometrists has granted its National Award to Mr. Pauné for his innovative work in this field.

20 Apr 2010

Researchers evaluate new treatment for coronary heart disease

Some patients with heart muscles seriously affected by coronary heart disease may soon be able to benefit from an innovative treatment.

13 Apr 2010

OptiMedica releases new details on femtosecond laser system for cataract surgery

OptiMedica Corp., a global ophthalmic device company, has released new details regarding the development of its proprietary femtosecond laser system for cataract surgery. The new system, which combines OptiMedica's breakthrough pattern scanning technology, an ultra-fast laser and integrated Optical Coherence Tomography imaging, is designed to dramatically improve the complex cataract procedure by replacing its most technically demanding and manual steps.

12 Apr 2010

Tβ4 therapy for ocular disorders closer to reality

RegeneRx Biopharmaceuticals, Inc. announced today that Tβ4, a synthetic version of a naturally occurring peptide that is the basis for the company's product candidates, will be the subject of three poster presentations at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to be held in Fort Lauderdale, Florida from May 2-6, 2010.

9 Apr 2010

ReVision Optics initiates US clinical trial of PresbyLens corneal inlay

ReVision Optics, a leading company in the research, development and manufacture of custom optical products to correct and maintain vision, announced today that it has begun its US clinical trial of the PresbyLens® corneal inlay. The clinical trial will evaluate the PresbyLens® corneal inlay for the correction of presbyopia, the age-related loss of near vision. The study began on April 6th with the treatment of three subjects by clinical investigator Dr. Stephen Slade of the Slade & Baker Vision Center in Houston, Texas.

9 Apr 2010

HOLCOMB C3-R cures bobsledder of impending blindness, helps win gold at 2010 Winter Olympics

It was an amazing triumph of the will, when the U.S. Bobsled Team, led by captain Steve Holcomb, took home the first Gold in 62 years at the 2010 Winter Olympics in Vancouver. An amazing feat, yet only the tip of the iceberg, for 2 years prior Holcomb underwent a brand new procedure to cure his impending blindness.

7 Apr 2010

Therapeutic swing for autism-spectrum disorder sheds metallic particles directly into eyes of children

The presence of metallic foreign bodies in the eye is an uncommon injury in children, so much so that two children with autism presenting with this injury led to detective work by two physicians that found the common cause.

7 Apr 2010

Special medicated contact lenses can help treat common eye disorders

The popular dietary supplement vitamin E, loaded into special medicated contact lenses, can keep glaucoma medicine near the eye - where it can treat that common disease- almost 100 times longer than possible with current commercial lenses, scientists reported here today.

25 Mar 2010

Avedro to acquire Corneal Collagen Crosslinking Phase III study rights from Peschke Meditrade

Avedro, Inc. today announced it has signed a definitive agreement with Swiss-based Peschke Meditrade GmbH to acquire the rights to its Phase III studies of Corneal Collagen Crosslinking for the treatment of progressive keratoconus and post LASIK ectasia. The two randomized, controlled, multi-site clinical trials are designed to assess the safety and efficacy of riboflavin/ultraviolet-A light for halting the progression of these degenerative disorders and the accompanying decline in patient’s visual acuity.

17 Mar 2010

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). However, the study, published in the March issue of Ophthalmology, showed that cell loss in DSAEK patients plateaued more quickly than in those who underwent PKP.

2 Mar 2010

DSAEK cornea transplant offers potential long-term benefits

One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty experienced greater cell loss overall compared to those who underwent penetrating keratoplasty, according to a new analysis of data collected from the Cornea Donor Study Investigator Group's 2008 Specular Microscopy Ancillary Study.

23 Feb 2010

International Stem Cell's human cornea technology: Clinical-commercial opportunities in Asia and Europe

International Stem Cell Corporation, announced today that multiple international meetings taking place between ISCO’s executive management and researchers and clinicians from commercial entities in both Asia and Europe revealed significant clinical-commercial opportunities for the company’s stem cell-derived human cornea technology in those regions.

17 Feb 2010